Trehalose 30 % stock solution
30 % (w/v) trehalose stock – alternative stabiliser for lyophilised and subcutaneous formulations. · GMP catalogue product · CT-00231
Trehalose 30 % stock solution is a defined trehalose concentrate for downstream processing. It is an alternative cryo-/lyo-protectant and stabiliser to sucrose for UF/DF and formulation, favoured for lyophilised and subcutaneous products. As a GMP-grade stock it is applied across monoclonal antibodies, vaccines, mRNA and cell & gene therapy.
One GMP quality. Trehalose 30 % stock solution is a GMP-grade catalogue product (CT-00231), manufactured by PAN-Celltech and released against a defined quality-control panel on every lot.
Why
- Alternative to sucrose – For lyophilised and subcutaneous formulations.
- Concentrated 30 % – Easy to add to the final matrix.
- GMP grade – Catalogue GMP quality, released per lot.
- Multi-application – Formulation stabiliser across platforms.
Specification
| Composition | 30 % (w/v) trehalose |
| Form | Excipient stock concentrate |
| Storage | 15-25 °C (room temperature) |
| Grade | GMP |
Ordering
| Grade | Article No. | Pack size |
|---|---|---|
| GMP | CT-00231 | 100 ml |
Other pack sizes are available on request.
Beyond compendial – on request. Every PAN downstream buffer is also available in a beyond-compendial version produced with WFI Beyond – Water for Injection engineered beyond the Ph. Eur./USP monograph – for the most demanding endotoxin and purity requirements. Available on request.
In the process – by application (upstream & downstream)
Trehalose 30 % stock solution is used at the following process steps across the biologics platforms it supports:
Monoclonal antibodies
- UF/DF and formulation – alternative cryo-/lyo-protectant.
Vaccines
- Formulation – stabiliser / cryoprotectant.
mRNA
- LNP formulation – cryoprotectant.
Cell & gene therapy
- Vector formulation – cryoprotection.
Frequently asked questions
What is Trehalose 30 % stock solution used for?
It is an alternative stabiliser and cryo-/lyo-protectant to sucrose for formulation.
Is it multi-application?
Yes, it is used across monoclonal antibodies, vaccines, mRNA and cell & gene therapy downstream.
One partner across every application. The same GMP downstream buffers support monoclonal antibodies, vaccines, mRNA and cell & gene therapy – explore the full GMP-grade catalogue or use the Smart Product Search.
Related: WFI Quality Water (CT-991500) · DPBS w/o Ca & Mg (CT-36500) · GMP-Grade Products